Stifel Maintains Buy on Sabra Health Care REIT, Raises Price Target to $16
Stifel Maintains Buy on Sabra Health Care REIT, Raises Price Target to $16
Stifel維持對Sabra Health Care REIT的買入，將目標股價提高至16美元
Stifel analyst Stephen Manaker maintains Sabra Health Care REIT (NASDAQ:SBRA) with a Buy and raises the price target from $14 to $16.
Stifel分析師斯蒂芬·馬納克維持Sabra Health Care REIT（納斯達克股票代碼：SBRA）的買入，並將目標股價從14美元上調至16美元。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。